Medical News

RSS

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Astellas Pharma US, Inc. and Medivation, Inc. today announced results of a national survey of men with advanced prostate cancer and caregivers of men with advanced prostate cancer.

26 Sep 2013

Alliqua enters into distribution agreement with Carolon Health Care Products

Alliqua Inc., a biomedical company offering a suite of drug delivery technologies and wound healing solutions, has entered into an agreement with Carolon Health Care Products through which it will gain both new sales distribution pathways and established customers.

26 Sep 2013

Center of Reproductive Medicine announces participation in Thrive-IVF Research Study

The Center of Reproductive Medicine today announced its participation in the Thrive-IVF Research Study, a Phase 2 clinical trial sponsored by Nora Therapeutics, Inc., to evaluate the efficacy, safety and tolerability of NT100 in women who have had repeated in vitro fertilization (IVF) failures despite having good quality embryos.

26 Sep 2013

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

PneumRx, Inc., a leader in interventional pulmonology, announced that over 1500 procedures have been performed using the RePneu Lung Volume Reduction Coil System for patients with severe emphysema.

26 Sep 2013

Nu Skin Enterprises receives FDA clearance to market facial spa device

Nu Skin Enterprises, Inc. today announced that it has received FDA clearance to market a facial spa device for over-the-counter cosmetic use. The company's 510(k) application was filed approximately one year ago.

26 Sep 2013

Affinity Health Plan's Medicare Advantage plans to be expanded into five counties

On October 1, 2013, Affinity Health Plan's Medicare Advantage plans, currently offered in the five boroughs of New York City, will become available in Nassau, Suffolk, Westchester, Rockland and Orange counties.

26 Sep 2013

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

Lumena Pharmaceuticals, a company developing oral therapeutics for rare liver diseases, today announced the initiation of a global clinical program to evaluate its drug candidate LUM001 in children with Alagille syndrome. The first patient has been dosed in the IMAGO Phase II study being conducted in the U.K., and enrollment of pediatric patients is expected to begin later this year in the ITCH Phase II study in the U.S.

26 Sep 2013

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

From today, patients with a very aggressive form of breast cancer known as HER2-positive, could benefit from a new faster, more efficient delivery method of Herceptin. The subcutaneous injection, given just beneath the skin, can be completed in 2-5 minutes, compared to the traditional, relatively time-consuming 30-90 minute intravenous infusion.

26 Sep 2013

Ampio Pharmaceuticals announces financing transaction of $25 million

Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced a financing transaction that will provide $25 million in gross proceeds to the Company. The financing is a registered direct placement of common stock of the Company.

26 Sep 2013

First Edition: September 26, 2013

Today's headlines include details regarding the ongoing congressional battle over the future of the health law in the context of avoiding a government shutdown, as well as the developments on the ground as the Oct. 1 launch of the health law's insurance marketplace nears.

26 Sep 2013

Celebrities join to mark the first Day of the Ex-Smoker

The day of celebration is to congratulate all ex-smokers, whether they are amongst the 400,000 who have signed up to kick the habit with the European Commission's "Ex-Smokers are Unstoppable" campaign, or have quit using other means.

26 Sep 2013

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

A new study from researchers at The University of Texas MD Anderson Proton Therapy Center found that the use of feeding tubes in oropharyngeal carcinoma cancer patients treated with intensity modulated proton therapy decreased by more than 50 percent compared to patients treated with intensity modulated radiation therapy.

26 Sep 2013

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

President Obama, President Clinton, and Senator Ted Cruz all spent a lot of time talking about Obamacare on Tuesday. But the real news came just as the day was ending, right at midnight, when the Department of Health and Human Services released data on insurance premiums available through the new Obamacare marketplaces. Several states had already released their data. With this report, HHS provided premium information for most of the rest. Overall, the numbers are pretty consistent with previous reports, albeit with some new and interesting wrinkles. It seems like mostly good news, though the law's critics would argue it vindicates some of their arguments, as well (Jonathan Cohn, 9/25).

26 Sep 2013

IRIDEX's MicroPulse Laser Therapy to be featured at EURETINA and ESCRS conferences

IRIDEX today announced a number of key international conferences and workshops that will feature its proprietary MicroPulse Laser Therapy for the treatment of diabetes and glaucoma related disorders.

26 Sep 2013

Consumer Reports launches web-based tool that offers personalized guidance on health insurance

Consumer Reports, the nonprofit consumer service organization empowering consumers for more than 75 years, today announced the launch of HealthLawHelper.org, an innovative web-based tool that offers personalized guidance to help consumers better understand how they may be affected by the Affordable Care Act.

26 Sep 2013

VolitionRx enters into distribution agreement with Active Motif for NuQ product line

VolitionRx Limited, a life sciences company focused on developing blood-based diagnostic tests for different types of cancer, today entered into an agreement with Active Motif, a leading provider of kits and reagents to enable epigenetics research.

26 Sep 2013

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Pittcon is pleased to announce it will be exhibiting at the next BioConference Live virtual event. BioConference Live, the largest producer of online-only conferences focused on life sciences, laboratory animal sciences and clinical diagnostics, has announced the upcoming “Cancer: Research, Discovery and Therapeutics” online-only conference.

26 Sep 2013

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

The Ohio State University Wexner Medical Center's Heart and Vascular Center has named Dr. Garret FitzGerald, professor of Medicine and Pharmacology; chair of the Department of Pharmacology and director of the Institute for Translational Medicine and Therapeutics at the Perelman School of Medicine at University of Pennsylvania, the recipient of the 2013 Jay and Jeanie Schottenstein Prize in Cardiovascular Sciences.

26 Sep 2013

New line of –30˚C biomedical freezers launched by Panasonic

Panasonic has launched a brand new line of -30˚C Biomedical freezers that provide cost-efficient and secure sample storage across a wide range of applications. A combination of technological advances in Panasonic’s new -30˚C freezers reduces energy consumption and improves temperature stability, delivering the effective, reliable environmental control needed when storing valuable materials such as vaccines, diagnostic samples, enzymes, culture media and reagents.

From PHC Europe B.V. 26 Sep 2013

People on health related social networking sites more likely to abstain from smoking

Smoking is a major public health problem, killing approximately 443,000 people every year in the United States. Quitting smoking can have a profound effect on a person's health, but it is also one of the hardest addictions to kick. A recent paper published in the Journal of Communication found that people who engage in health specific social networking sites found it easier to quit smoking.

26 Sep 2013

Medical News

Astellas Pharma US, Medivation report results of advanced prostate cancer patient, caregiver survey

Alliqua enters into distribution agreement with Carolon Health Care Products

Center of Reproductive Medicine announces participation in Thrive-IVF Research Study

PneumRx performs over 1500 RePneu LVRC treatments for patients with severe emphysema

Nu Skin Enterprises receives FDA clearance to market facial spa device

Affinity Health Plan's Medicare Advantage plans to be expanded into five counties

Lumena Pharmaceuticals initiates LUM001 clinical program in children with ALGS

HER2-positive breast cancer patients could now benefit from Herceptin SC injection

Ampio Pharmaceuticals announces financing transaction of $25 million

First Edition: September 26, 2013

Celebrities join to mark the first Day of the Ex-Smoker

Use of feeding tubes in OPC cancer patients treated with IMPT decreased by 50%

Viewpoints: Health law premium rates reveal 'mostly good news' but renew critics arguments; 'Cruz-ing for a bruising;'

IRIDEX's MicroPulse Laser Therapy to be featured at EURETINA and ESCRS conferences

Consumer Reports launches web-based tool that offers personalized guidance on health insurance

VolitionRx enters into distribution agreement with Active Motif for NuQ product line

Pittcon to exhibit at BioConference Live’s “Cancer: Research, Discovery and Therapeutics” online-only event

Ohio State's Heart and Vascular Center names Garret FitzGerald as recipient of Schottenstein Prize

New line of –30˚C biomedical freezers launched by Panasonic

People on health related social networking sites more likely to abstain from smoking

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News